Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis

Dupilumab normalizes expression of genes associated with fibrosis, remodeling, and barrier function in patients with eosinophilic esophagitis